1. <button id="o6o44"><dd id="o6o44"><cite id="o6o44"></cite></dd></button>

  2. <b id="o6o44"></b>

  3. <xmp id="o6o44"></xmp>
      1. [Print page][Close page][Font Size: BigNormalSmall]

        SIP sees ever-increasing number of promising biomedicine businesses

        Date:2020-03-25 15:13|Source:
        SIP has seen an ever-increasing number of promising biomedicine businesses. It is now home to over 1,400 businesses of the kind which are jointly propelling a fast expansion of the biomedical ecosystem in the area.
        Chinese pharmaceutical conglomerate Hengrui Medicine received the approval early this month from National Medical Products Administration (NMPA) of China for marketing Camrelizumab for Injection, a humanized anti-PD-1 monoclonal antibody that is applicable to treatment of patients with refractory hepatocellular carcinoma. Suzhou Shengdiya Biomedicine Co Ltd, a wholly-owned company of Hengrui Medicine in SIP, plans to make about 600,000 pieces of the new drugs this year.
         
        BASECARE, a leading biomedicine company in SIP’s BioBAY, recently received from NMPA the approval for marketing its new testing kit for preimplantation genetic screening (PGS) aimed at detecting chromosome abnormalities of IVF (in-vitro fertilization) embryos. The testing kit, known as BasePGT-ATM, is reportedly the first product approved under the country’s “Green Channel” program which is designed to facilitate registration and marketing of innovative medical products, and the first registered product of its kind nationwide. 
        Apart from that, many other biomedicine businesses have made remarkable achievements in their fields. 
        这里只有精品久久,亚洲精品综合久久,欧美一区二区视频在线,国产精品久久久久久久妇,国产九九精品,亚洲视频三区,一级a爱视频在线观看
        1. <button id="o6o44"><dd id="o6o44"><cite id="o6o44"></cite></dd></button>

        2. <b id="o6o44"></b>

        3. <xmp id="o6o44"></xmp>